Clinical Trial Update: A Single Arm, Phase II Exploratory Clinical Study of Pemitinib in Advanced Gastric Cancer With Previous Standard Therapy Failure the FGFR Variant [Phase 2]

View source ↗

Summary

A single-arm Phase II exploratory trial of pemitinib in advanced gastric cancer with FGFR variant after standard therapy failure is being conducted, with status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Unresectable Gastric Cancer

Drugs mentioned

• Pemitinib (pematinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Locally Advanced Unresectable Gastric Cancer | Phase 2 | Status: UNKNOWN